We are live on ! Find out more
RPC

Rossmore Private Capital Portfolio holdings

AUM $1.24B
1-Year Est. Return 28.92%
This Fund
S&P 500
This Quarter Est. Return
+2.34%
1 Year Est. Return
+28.92%
3 Year Est. Return
+75.43%
5 Year Est. Return
+104.51%
10 Year Est. Return
–
AUM
$761M
AUM Growth
-$2.85M
Cap. Flow
-$12.6M
Cap. Flow %
-1.65%
Top 10 Hldgs %
40.05%
Holding
237
New
4
Increased
56
Reduced
85
Closed
6

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$1.18M
2
TSLA icon
Tesla
TSLA
+$662K
3
RSP icon
Invesco S&P 500 Equal Weight ETF
RSP
+$616K
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$551K
5
TSM icon
TSMC
TSM
+$381K

Top Sells

Rank Stock Value
1
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$5.45M
2
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$2.98M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$1.09M
4
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$808K
5
BMY icon
Bristol-Myers Squibb
BMY
+$606K

Sector Composition

Rank Sector Weight
1 Technology 17.75%
2 Energy 13.46%
3 Healthcare 11.93%
4 Financials 9.45%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VBK icon
226
Vanguard Morningstar Small-Cap Growth ETF
VBK
$24.1B
$209K 0.03%
835
– –
TD icon
227
Toronto Dominion Bank
TD
$197B
$209K 0.03%
3,796
– –
SLRC icon
228
SLR Investment Corp
SLRC
$719M
$161K 0.02%
10,000
– –
GSAT icon
229
Globalstar
GSAT
$10.8B
$41.3K 0.01%
2,460
– –
MIN
230
Aberdeen Intermediate Income Fund
MIN
$275M
$27.3K ﹤0.01%
10,275
– –
MTNB icon
231
Matinas BioPharma
MTNB
$1.86M
$2.77K ﹤0.01%
350
– –
GILD icon
232
Gilead Sciences
GILD
$168B
– –
-5,686
Closed -$417K
HUN icon
233
Huntsman Corp
HUN
$1.83B
– –
-8,350
Closed -$217K
RAVI icon
234
FlexShares Ultra-Short Income Fund
RAVI
$1.49B
– –
-5,654
Closed -$427K
VLUE icon
235
iShares MSCI USA Value Factor ETF
VLUE
$9.45B
– –
-2,500
Closed -$271K
WBS icon
236
Webster Financial
WBS
$12.6B
– –
-4,006
Closed -$203K
PXD
237
DELISTED
Pioneer Natural Resource Co.
PXD
– –
-1,000
Closed -$263K
6 7 8 9
10

Similar funds

MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
GX
Greylock XIV Menlo Park, California $1.24B AUM
HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
FLII
First Long Island Investors Jericho, New York $1.23B AUM 14.42% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
HTHT
Hemenway Trust Hemenway Trust Salem, New Hampshire $1.24B AUM 16.47% 1-Year Est. Return

Rossmore Private Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Rossmore Private Capital held 237 positions worth $761M, down 0.37% from $764M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Trading was light in Q2 2024: portfolio turnover was 4.2%. Rossmore Private Capital opened 4 new positions and exited 6, leaving the 237-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Energy and Healthcare.

  • Rossmore Private Capital's largest Q2 2024 buy was TSMC: 2,510 shares worth $436K.
  • Rossmore Private Capital added most to AstraZeneca in Q2 2024, an estimated $1.18M increase.
  • Rossmore Private Capital's biggest Q2 2024 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $5.45M.
  • Rossmore Private Capital fully exited FlexShares Ultra-Short Income Fund in Q2 2024, selling an estimated $427K.
  • Rossmore Private Capital's ten largest holdings make up 40% of its $761M portfolio in Q2 2024.
  • Rossmore Private Capital opened 4 new positions and closed 6 in Q2 2024.
  • Rossmore Private Capital's portfolio value fell 0.37% quarter-over-quarter to $761M.

Based on Rossmore Private Capital's 13F filing for Q2 2024, filed 12 Aug 2024.